new glp 1 drug retatrutide Retatrutide—A Game Changer in Obesity Pharmacotherapy Retatrutide Research: Triple Agonist Mechanism

Tirzepatide helped redefine expectations for non-surgical weight loss, while retatrutide appears to push those results even further by targeting an additional metabolic pathway

How the Field Arrived at These Two Molecules Neither compound appeared in a vacuum

Engaging the glucagon receptor shifts the research focus from simple insulin production to active energy expenditure

That framing appeals to those who appreciate specificity as opposed to vague advice

A simple log turns a vague sense of progress into hard data you can trust and adjust from

For bodybuilders who include cardiovascular training in their cutting protocol, this means: Steady-state cardio may feel harder at the same intensity HIIT sessions may need longer recovery intervals Overall cardiovascular training volume may need reduction Monitor resting heart rate trends to identify if the elevation becomes clinically significant Skin and appearance effects Skin sensitivity changes have been reported by some retatrutide users